Baillie Gifford & Co
KDNY

Baillie Gifford & Co’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-463,945
Closed -$17.8M 303
2023
Q2
$17.8M Sell
463,945
-22,650
-5% -$870K 0.02% 186
2023
Q1
$11.3M Sell
486,595
-3,113
-0.6% -$72.1K 0.01% 215
2022
Q4
$12.8M Buy
489,708
+25,394
+5% +$665K 0.01% 206
2022
Q3
$9.13M Sell
464,314
-40,511
-8% -$796K 0.01% 219
2022
Q2
$8.83M Sell
504,825
-306,054
-38% -$5.35M 0.01% 218
2022
Q1
$13.3M Sell
810,879
-32,933
-4% -$539K 0.01% 223
2021
Q4
$13.8M Buy
843,812
+6,236
+0.7% +$102K 0.01% 235
2021
Q3
$10.7M Sell
837,576
-1,804
-0.2% -$23K 0.01% 245
2021
Q2
$11.9M Sell
839,380
-6,105
-0.7% -$86.2K 0.01% 242
2021
Q1
$13.1M Buy
845,485
+801
+0.1% +$12.4K 0.01% 235
2020
Q4
$13.4M Sell
844,684
-3,421,296
-80% -$54.3M 0.01% 214
2020
Q3
$10.4M Sell
4,265,980
-16,740
-0.4% -$40.7K 0.01% 210
2020
Q2
$9.89M Buy
4,282,720
+3,396
+0.1% +$7.85K 0.01% 196
2020
Q1
$11.7M Buy
4,279,324
+47,068
+1% +$129K 0.01% 164
2019
Q4
$5M Buy
4,232,256
+105,800
+3% +$125K ﹤0.01% 190
2019
Q3
$4.37M Buy
4,126,456
+55,732
+1% +$59.1K 0.01% 193
2019
Q2
$6.27M Buy
4,070,724
+239,298
+6% +$369K 0.01% 197
2019
Q1
$15.2M Buy
3,831,426
+170,253
+5% +$678K 0.02% 174
2018
Q4
$9.67M Buy
3,661,173
+584,348
+19% +$1.54M 0.01% 184
2018
Q3
$22.6M Buy
3,076,825
+266,317
+9% +$1.96M 0.02% 151
2018
Q2
$19.7M Buy
2,810,508
+1,153,771
+70% +$8.08M 0.02% 145
2018
Q1
$15.4M Buy
1,656,737
+614,124
+59% +$5.71M 0.02% 155
2017
Q4
$7.82M Buy
1,042,613
+489,523
+89% +$3.67M 0.01% 178
2017
Q3
$5.89M Buy
553,090
+130,390
+31% +$1.39M 0.01% 180
2017
Q2
$4.82M Buy
422,700
+132,700
+46% +$1.51M 0.01% 185
2017
Q1
$3.12M Hold
290,000
﹤0.01% 181
2016
Q4
$3.31M Hold
290,000
0.01% 185
2016
Q3
$3.61M Hold
290,000
0.01% 184
2016
Q2
$3.28M Buy
290,000
+60,000
+26% +$679K 0.01% 181
2016
Q1
$2.95M Buy
+230,000
New +$2.95M 0.01% 186